Molecular Diagnostics Market

Molecular diagnostics is being applied to an increasingly wide range of applications in infectious disease, oncology, and genetic disease diagnosis and screening and to a number of emerging applications in other diseases. The global market for molecular diagnostics is expected to grow at a CAGR of 10.8% between 2019 and 2024, reaching a value of more than $12bn. The market is undergoing rapid expansion due to the unprecedented global demand for COVID-19 testing via molecular methods, but other segments are also experiencing significant growth. Leading competitors in the market include Roche, Danaher, bioMérieux, Qiagen, and Hologic, among others.

This comprehensive medical market and technology report provides:

• an overview of molecular diagnostics technology, including
  companion diagnostics
• in-depth market and competitive analyses
• product portfolios offered by leading manufacturers
• disease prevalence data
• blood collection trends

Markets covered by this analysis include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.